연구동향
기준 논문: 알츠하이머병에 대한 근거중심 처방
이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.
10,306편 검색→1,942편 판독→225편 선별 (관련도 0.5 이상)
질문과 PubMed 검색식 보기
질문: Evidence-based pharmacological treatment of Alzheimer disease with cholinesterase inhibitors and memantine
(Alzheimer*[tiab] OR "Alzheimer disease"[mh] OR "Alzheimer's disease"[tiab]) AND (cholinesterase inhibitor*[tiab] OR donepezil[tiab] OR rivastigmine[tiab] OR galantamine[tiab] OR memantine[tiab] OR "Cholinesterase Inhibitors"[mh] OR "Memantine"[mh]) AND (drug therapy[sh] OR treatment[tiab] OR therapeutic use[sh] OR pharmacotherapy[tiab])출판 연도
선별된 225편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.
주제별 논문
주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.
01dementia · risk144편
- 0.94
Nakamura Y, Kurokawa T, Terashima S et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.94
Nakamura Y, Kim R, Nishiyama K et al. · Geriatrics & gerontology international · 2023
- 0.93
Tu H, Zhou S, Lin J · British journal of hospital medicine (London, England : 2005) · 2025
- 0.93
Memantine in Korean Alzheimer's disease: A prospective real-world REMIND study
Na S, Kim HS, Kim GH et al. · International psychogeriatrics · 2026
- 0.92
Kim T, Hong YJ, Kim M et al. · Alzheimer's research & therapy · 2026
- 0.92
Zuliani G, Brombo G, Romagnoli T et al. · GeroScience · 2026
- 0.92
Lecerf S, Guinebretiere O, Bentegeac R et al. · The Lancet regional health. Europe · 2026
- 0.92
Chen C, Mo M, Akerman M et al. · Alzheimer's research & therapy · 2025
- 0.92
Nakamura Y, Omori T, Kim R et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.91
Wang H, Lv P · American journal of translational research · 2025
- 0.90
Differential response to donepezil in MRI subtypes of mild cognitive impairment
Diaz-Galvan P, Lorenzon G, Mohanty R et al. · Alzheimer's research & therapy · 2023
- 0.89
Chen Y, Tong Z, Wang H et al. · Journal of neurology · 2026
- 0.89
Kim HJ, Shim Y, Han HJ et al. · Neurology and therapy · 2023
- 0.89
Nakamura Y, Narita K, Kim R et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.88
Abbas Raja A, Amjad A, Choudhary A et al. · Cureus · 2025
- 0.88
Nakamura Y, Tsushio T, Tanahashi M et al. · Alzheimer disease and associated disorders · 2026
- 0.88
Fischer MHF, Zibrandtsen IC, Johannsen P et al. · Journal of Alzheimer's disease reports · 2024
- 0.87
Real-world effects of anti-dementia treatment on mortality in patients with Alzheimer s dementia
Nielsen RE, Grontved S, Lolk A et al. · Medicine · 2022
- 0.87
Yaghmaei E, Lu H, Ehwerhemuepha L et al. · Communications medicine · 2024
- 0.87
Deng X, Zeng Y, Ding D · Pakistan journal of pharmaceutical sciences · 2026
- 0.87
Guo Y, Zhang Z, Chen B et al. · Journal of integrative neuroscience · 2026
- 0.87
Zuliani G, Boscolo Bragadin F, Romagnoli T et al. · International journal of geriatric psychiatry · 2026
- 0.86
Shahim B, Xu H, Haugaa K et al. · European heart journal. Cardiovascular pharmacotherapy · 2024
- 0.86
Lee CY, Wang WF, Hsu JL et al. · Journal of Alzheimer's disease reports · 2025
- 0.86
Yaghmaei E, Pierce A, Lu H et al. · PloS one · 2023
- 0.85
Lee YC, Shi SM, Sison SM et al. · JAMA network open · 2024
- 0.84
Yang Y, Huh K, Kwak YT · Geriatrics & gerontology international · 2024
- 0.84
Lee LH, Wu SC, Ho CF et al. · PloS one · 2023
- 0.84
Ho BL, Liu CF, Huang YB et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.84
Memantine in the treatment of dementia: a nationwide real-world analysis
Halmos PM, Dobi B, Vinnai P et al. · GeroScience · 2026
- 0.83
Edmiston EA, Bej TA, Wilson B et al. · Therapeutic advances in infectious disease · 2023
- 0.83
Garcia-Alberca JM, De La Guia P, Gris E et al. · Journal of Alzheimer's disease : JAD · 2024
- 0.82
Efficacy of donepezil combined with rehabilitation training in the treatment of Alzheimer's disease
Yi Y, Deng X · Pakistan journal of medical sciences · 2025
- 0.82
Ozge A, Ghouri R, Oksuz N et al. · Frontiers in neurology · 2023
- 0.82
Huang Y, Gamble JM, Juurlink DN et al. · Pharmacoepidemiology and drug safety · 2026
- 0.81
Dedebant E, Even M, Tornqvist M et al. · medRxiv : the preprint server for health sciences · 2026
- 0.81
Zeng Y, Liu B, Zhou L et al. · Expert opinion on drug safety · 2026
- 0.81
Kim TE, Bae JW, Hong S et al. · The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
- 0.81
Byeon G, Byun MS, Yi D et al. · Journal of Alzheimer's disease : JAD · 2024
- 0.81
Liu W, Li Y, Qin W et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.80
Dai M, Guo Z, Xia H et al. · Aging clinical and experimental research · 2024
- 0.80
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer's Disease
Gareri P, Cotroneo AM, Montella R et al. · Journal of Alzheimer's disease : JAD · 2024
- 0.80
Kim GW, Park K, Kim YH et al. · Journal of clinical medicine · 2023
- 0.79
Padovani A, Falato S, Pegoraro V · Current medical research and opinion · 2023
- 0.79
Lai HY, Meng LC, Ye YJ et al. · British journal of clinical pharmacology · 2026
- 0.78
Garcia-Alberca JM, Gris E, de la Guia P et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.78
- 0.77
Wang X, Zhang W, He J et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.76
Hegedus E, Pakaski M, Gosztolya G et al. · PloS one · 2024
- 0.76
Phatthanasobhon S, Singkham N, Na-Ek N et al. · Archives of gerontology and geriatrics · 2025
- 0.76
Dan Z, Li H, Xie J · Medicine · 2023
- 0.76
Cholinesterase inhibitor use in amyloid PET-negative mild cognitive impairment and cognitive changes
Pyun JM, Park YH, Kang MJ et al. · Alzheimer's research & therapy · 2024
- 0.76
- 0.76
Shimazu T, Hoshino E, Nakaseko M et al. · Neuropsychiatric disease and treatment · 2026
- 0.76
Rizi ZS, Shams L, Rad FR et al. · Journal of molecular neuroscience : MN · 2024
- 0.76
Efficacy of Acetylcholinesterase Inhibitors in the Logopenic Variant of Primary Progressive Aphasia
Carrier-Auclair J, Lavoie M, Tastevin M et al. · Dementia and geriatric cognitive disorders · 2025
- 0.75
Lanskey JH, Jafarian A, Hughes LE et al. · Molecular psychiatry · 2026
- 0.75
Hsieh SW, Hsiao CY, Yang YH et al. · Journal of Alzheimer's disease reports · 2025
- 0.75
Chotiyanonta JS, Onda K, Nowrangi MA et al. · Frontiers in pharmacology · 2023
- 0.75
Discontinuation of Alzheimer Disease Medications in Patients Receiving Home Care Medicine
Kidana K, Yamaga R, Fujii H et al. · Alzheimer disease and associated disorders · 2024
- 0.74
Sun H, Lv C, Zhang X et al. · Clinical interventions in aging · 2024
- 0.74
Swerdlow NR, Sprock J, Gonzalez CE et al. · Psychiatry research · 2025
- 0.74
Otani N, Kanda K, Ngatu NR et al. · Medicina (Kaunas, Lithuania) · 2024
- 0.74
Reimers-Wessberg M, Xu H, Fastbom J et al. · European heart journal. Cardiovascular pharmacotherapy · 2025
- 0.73
Furneri G, Varrasi S, Guerrera CS et al. · Aging clinical and experimental research · 2024
- 0.73
Tseng WYI, Hsu YC, Huang LK et al. · Journal of Alzheimer's disease : JAD · 2024
- 0.72
Morden NE, Chyn D, Meara E · Medical care · 2025
- 0.72
Xu H, Garcia-Ptacek S, Bruchfeld A et al. · Kidney international · 2023
- 0.72
Rahbek MT, Kildegaard H, Hallas J et al. · Alzheimer's research & therapy · 2026
- 0.72
Lee CY, Hsu CW, Tseng PT et al. · Alzheimer's research & therapy · 2026
- 0.72
Guo Z, Wei F, Hou H et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
- 0.72
Lv J, Cai X, Yang Z et al. · Expert review of pharmacoeconomics & outcomes research · 2026
- 0.72
Tzieras I, Manolopoulos A, Tweedie D et al. · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
- 0.71
Kim MG, Woo SH, Kim GW et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.71
Cumulative Anticholinergic Burden and Risk of Delirium Among Older Adults with Alzheimer's Disease
Talwar A, Sherer J, Abughosh S et al. · Pharmacy (Basel, Switzerland) · 2026
- 0.71
Zhang SQ, Ma S, Yang TS et al. · Zhen ci yan jiu = Acupuncture research · 2024
- 0.71
Jiang X, Lv G, Franklin J et al. · BMC geriatrics · 2025
- 0.70
Onda K, Chotiyanonta JS, Cowley HP et al. · International psychogeriatrics · 2025
- 0.70
Li S, Qian W, Zhang Z et al. · Frontiers in neurology · 2025
- 0.70
Pinol-Ripoll G, Salas Carrillo M · Patient preference and adherence · 2025
- 0.70
Investigation of the gait parameters after donepezil treatment in patients with alzheimer' s disease
Bizpinar O, Onder H · Applied neuropsychology. Adult · 2025
- 0.69
- 0.69
Yang S, Fan D, Su S et al. · Zhongguo zhen jiu = Chinese acupuncture & moxibustion · 2024
- 0.68
Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer's disease
Chikermane SG, Li J, Aparasu RR · Archives of gerontology and geriatrics · 2025
- 0.68
Effects of Cholinesterase Inhibitor Medication on QTc Interval in Memory Clinic Patients
Isotalo HK, Lehtovaara JK, Ekblad LL et al. · The Annals of pharmacotherapy · 2026
- 0.68
Zuniga-Santamaria T, Perez-Aldana BE, Fricke-Galindo I et al. · Neurology international · 2025
- 0.67
Wang D, Ling Y, Harris K et al. · AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024
- 0.67
Swerdlow NR, Joshi YB, Sprock J et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.67
Donepezil increases angiogenic potential in patients with Alzheimer's disease
Lee M, Kim M · Journal of Alzheimer's disease : JAD · 2026
- 0.67
Du Y, Li J, Han F et al. · Current Alzheimer research · 2026
- 0.67
Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)
DiBello JR, Lu Y, Swartz J et al. · BMC neurology · 2023
- 0.67
Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease
Sato S, Sasabuchi Y, Yamana H et al. · Journal of the American Medical Directors Association · 2026
- 0.66
Ji X, Liang L · Actas espanolas de psiquiatria · 2024
- 0.66
Guan J, Noviasky J, Watanabe JH · The Senior care pharmacist · 2024
- 0.65
Impact of modifications to antidementia drug reimbursement in France: Analysis of the FRA-DEM cohort
Couret A, Gardette V, Renoux A et al. · British journal of clinical pharmacology · 2024
- 0.65
Antidementia Medication Use in Nursing Home Residents
Ott BR, Hollins C, Tjia J et al. · Journal of geriatric psychiatry and neurology · 2024
- 0.64
Morris C, Mok PLH, Robinson DL et al. · PloS one · 2026
- 0.64
Wang D, Ling Y, Harris K et al. · medRxiv : the preprint server for health sciences · 2023
- 0.63
Talwar A, Chatterjee S, Sherer J et al. · Drugs & aging · 2024
- 0.62
Nakamura Y, Omori T, Nishiyama K et al. · Alzheimer disease and associated disorders · 2024
- 0.62
Umbria M, Exposito J, Gasol M et al. · Frontiers in pharmacology · 2026
- 0.62
Dangpiaei S, Kamal KM, Shoair OA et al. · Journal of managed care & specialty pharmacy · 2026
- 0.61
Evaluating the Cost-Effectiveness of Pharmacological Therapy in Alzheimer Disease in Brazil
Price PU, Heggie R, Moriguti JC et al. · Value in health regional issues · 2025
- 0.61
Zhang Y, Sun Y, Hu X et al. · International journal of surgery (London, England) · 2024
- 0.61
Treatment patterns of symptomatic treatments for Alzheimer's disease and related dementias
Deng H, Lee TA, Gaber CE et al. · BMC geriatrics · 2025
- 0.60
Cai L, Zhao X, Liao C et al. · Frontiers in psychiatry · 2026
- 0.60
Choi M, Jin BH, Keum DH et al. · Clinical pharmacology in drug development · 2025
- 0.60
Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients
Grau-Jurado P, Mostafaei S, Xu H et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.60
Li M, Qin Z, Chen H et al. · Brain sciences · 2023
- 0.60
Rampa L, Santangelo R, Gaspardone C et al. · The American journal of cardiology · 2023
- 0.60
Prescribing memantine in general practice in England: a mixed-methods study
Carter M, Butterworth J, Fox C et al. · BJGP open · 2025
- 0.60
Nakamura Y, Omori T, Nishiyama K et al. · Alzheimer disease and associated disorders · 2025
- 0.59
Wei YT, Li L, Xie WT et al. · Neuropsychiatric disease and treatment · 2026
- 0.59
Dauphinot V, Laurent M, Prodel M et al. · Alzheimer's research & therapy · 2024
- 0.59
Maas C, Fang L, Mathey E et al. · Scientific reports · 2026
- 0.59
Xie Z, Locke D, Shandera-Ochsner A et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.58
Dubois B, Lopez-Arrieta J, Lipschitz S et al. · Alzheimer's research & therapy · 2023
- 0.58
Shim SR, Kim JY, Kwon KY et al. · PloS one · 2024
- 0.58
Fortea J, Ferrer-Picon E · Expert review of neurotherapeutics · 2025
- 0.57
Chen Y, Lai M, Tao M · Medicine · 2024
- 0.57
Effect of donepezil on bone metabolism among older adults with Alzheimer's disease
North R, Liu AJ, Pieper C et al. · Contemporary clinical trials · 2025
- 0.56
Using artificial intelligence to learn optimal regimen plan for Alzheimer's disease
Bhattarai K, Rajaganapathy S, Das T et al. · Journal of the American Medical Informatics Association : JAMIA · 2023
- 0.56
Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact
Olazaran J, Carnero-Pardo C, Fortea J et al. · Alzheimer's research & therapy · 2023
- 0.55
Yajima R, Ishiguro T, Michikawa M et al. · Journal of Alzheimer's disease reports · 2026
- 0.55
Acupuncture as an adjunct therapy for mild Alzheimer's disease: A randomized clinical trial
Kong X, Han R, Fan X et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.55
Anti-dementia drugs: a descriptive study of the prescription pattern in Italy
Ippoliti I, Ancidoni A, Da Cas R et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
- 0.54
Heo RJ, Negida A, Barrett MJ et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.53
Qian H, Yu C, Zhu H et al. · Clinical and translational science · 2023
- 0.53
Shaik NS, Balya H, Ramamurthy S et al. · Dementia & neuropsychologia · 2026
- 0.53
Leijenaar JF, Ingala S, Sudre CH et al. · Cerebral circulation - cognition and behavior · 2022
- 0.53
Miller A, Desai A, Roley LT et al. · Frontiers in aging neuroscience · 2022
- 0.52
Lee E, Kang S, Ye BS et al. · Journal of Korean medical science · 2025
- 0.52
Boroje I, Sanchez-Solino O, Yue EX et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.52
Annual Wellness Visits and New Dementia Medication Prescriptions Among US Medicare Beneficiaries
Milani SA, Kuo YF, Shan Y et al. · JAMA network open · 2026
- 0.52
Dementia medications and the use of psychotropic drugs: A cross-sectional study in Saudi healthcare
Hajjar SH, Alamri SH, AlFouzan MA et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.52
Desai A, Agbomi LL, Nathaniel AI et al. · Geriatric nursing (New York, N.Y.) · 2026
- 0.52
Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta-analysis
Nham T, Garcia MC, Tsang KLJ et al. · Journal of the American Geriatrics Society · 2024
- 0.51
Kumar CS, Varghese M, Duddu V et al. · Indian journal of psychiatry · 2023
- 0.51
Bittner N, Funk CSM, Schmidt A et al. · Drugs & aging · 2023
- 0.51
Wu Y, Di Y, Wang H et al. · Ageing research reviews · 2026
- 0.51
Uptake and safety profile of anti-amyloid immunotherapies in routine clinical practice
Lusk JB, Fitch KV, Johnson KG et al. · Journal of Alzheimer's disease reports · 2026
- 0.50
Milani SA, Westra J, Kuo YF et al. · Drugs & aging · 2025
- 0.50
Real-World Use of Symptomatic Treatments in Early Alzheimer's Disease
Garcia MJ, Leadley R, Lang S et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.50
Rataj A, Alcusky M, Baek J et al. · Medical care · 2024
02rats · oxidative stress30편
- 0.75
Yeram N, Dalvi SM, Kale VP et al. · Neurology India · 2025
- 0.73
Abdel-Aal RA, Abdelnabi S, Badary DM et al. · European journal of pharmacology · 2026
- 0.72
Bali ZK, Bruszt N, Gonter K et al. · Behavioral and brain functions : BBF · 2025
- 0.69
Mahajan E, Raja A, Sharma AR et al. · Experimental neurology · 2024
- 0.67
Alrikabi A, Allahyani W, Shaghath A et al. · Frontiers in neuroscience · 2025
- 0.65
Abdel-Aal RA, Meligy FY, Maghraby N et al. · Brain research · 2025
- 0.65
Jadhav R, Kulkarni YA · Molecules (Basel, Switzerland) · 2023
- 0.64
Neuroprotective Effects of Liraglutide and/or Rivastigmine Combination on the Rat Hippocampus
Abdel-Aal RA, Hareedy MS, Badary DM et al. · Drug development research · 2025
- 0.64
Jadhav R, Kulkarni YA · Antioxidants (Basel, Switzerland) · 2023
- 0.63
The involvement of neuroinflammation in an animal model of dementia and depression
Zabot GC, Medeiros EB, Macarini BMN et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2024
- 0.63
Robinson L, Bray J, Melis V et al. · Behavioural pharmacology · 2026
- 0.61
Effects of baicalein with memantine on aluminium chloride-induced neurotoxicity in Wistar rats
Jadhav R, Kulkarni YA · Frontiers in pharmacology · 2023
- 0.60
Dragomir AF, Barbu AC, Stoleru S et al. · Biomedicines · 2026
- 0.57
Huang H, Fang C, Niu H et al. · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2023
- 0.57
El-Baga SE, Hassan MH, Awadalla EA et al. · Neurochemical research · 2026
- 0.57
Ekundayo BE, Adewale OB, Obafemi BA et al. · Cell biochemistry and function · 2024
- 0.56
Abdel-Lah ES, Sherkawy HS, Mohamed WH et al. · Inflammopharmacology · 2025
- 0.56
Dondaine T, Rein W, Micallef J et al. · Experimental and clinical psychopharmacology · 2026
- 0.55
Anoush M, Bijani S, Moslemifar F et al. · Behavioural neurology · 2023
- 0.55
Al-Sawasany AS, Fayed HM, Mahmoud BF et al. · Journal of biochemical and molecular toxicology · 2025
- 0.53
Metabolic Activation and Cytotoxicity of Donepezil Induced by CYP3A4
Zheng J, Zhao G, Hu Z et al. · Chemical research in toxicology · 2024
- 0.53
Kumari K, Kumar S, Sinha RK et al. · Cureus · 2023
- 0.53
Ozsoy S, Cakir Z, Akcay E et al. · Turkish journal of medical sciences · 2023
- 0.52
Ramires Junior OV, Silveira JS, Gusso D et al. · Chemico-biological interactions · 2024
- 0.52
Eraky SM, Ramadan NM, Abo El-Magd NF · International journal of biological macromolecules · 2023
- 0.51
Cinar E, Mutluay SU, Baysal I et al. · Noro psikiyatri arsivi · 2022
- 0.50
Bashir DJ, Manzoor S, Sarfaraj M et al. · ACS omega · 2023
- 0.50
Abdel-Lah ES, Hamad N, Taha AF et al. · Drug development research · 2025
- 0.50
Nawar NF, Beltagy DM, Mohamed TM et al. · Toxicology research · 2024
- 0.50
Ji Y, Cui X, Ding Z et al. · Journal of Alzheimer's disease : JAD · 2026
03mice · expression24편
- 0.79
Fabrik I, Kupcik R, Fabrikova D et al. · Proteomics · 2025
- 0.75
Yu SP, Gu X, Jiang MQ et al. · Cells · 2025
- 0.73
Xu M, Yue Y, Huang J · Journal of pharmaceutical and biomedical analysis · 2023
- 0.72
Lee D, Shen AM, Shah M et al. · International journal of molecular sciences · 2024
- 0.71
Liu J, Liu K, Cui X et al. · Biochemical and biophysical research communications · 2025
- 0.67
Wang H, Wang Y, Lv Z et al. · Brain sciences · 2026
- 0.67
Effect of Cerebralcare Granule(R) combined with memantine on Alzheimer's disease
Yang M, Zhang X, Qiao O et al. · Journal of ethnopharmacology · 2024
- 0.67
Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice
Kondak C, Leith M, Baddeley TC et al. · International journal of molecular sciences · 2023
- 0.66
Disease-modifying effect of donepezil on APP/PS1 mice at different stages of Alzheimer's disease
Zueva I, Belyaev G, Petrov K · Molecular and cellular biochemistry · 2025
- 0.65
Li Y, Wu M, Kong M et al. · Microorganisms · 2023
- 0.62
Jing S, Wang Y, Liu Y et al. · Journal of medical biochemistry · 2025
- 0.62
Schwab K, Lauer D, Magbagbeolu M et al. · Brain research bulletin · 2024
- 0.61
Effect of donepezil hydrochloride on the transgenic Drosophila expressing human Abeta-42
Siddique YH, Naz F, Rahul et al. · The International journal of neuroscience · 2024
- 0.61
Gu X, Yu SP, Jiang MQ et al. · Neuroscience bulletin · 2026
- 0.60
Kim JS, Kim MG, Ryu JE et al. · Journal of ethnopharmacology · 2024
- 0.58
Brisendine MH, Nieves-Esparcia DQ, Willoughby OS et al. · bioRxiv : the preprint server for biology · 2025
- 0.57
Chen G, Zhang K, Sun M et al. · Neuropharmacology · 2025
- 0.55
Brisendine MH, Nieves-Esparcia DQ, Willoughby OS et al. · Aging cell · 2026
- 0.54
Belyaev GP, Petrov KA, Semenov VE et al. · Bulletin of experimental biology and medicine · 2025
- 0.53
Tarif AMM, Huhe H, Ohno M · Psychopharmacology · 2024
- 0.52
Kim EH, Lee YJ, Moon YS et al. · Frontiers in aging neuroscience · 2025
- 0.52
Schwab K, Robinson L, Annschuetz A et al. · Brain research bulletin · 2025
- 0.52
Zadrozny M, Drapich P, Gasiorowska-Bien A et al. · Cells · 2024
- 0.51
Freyssin A, Carles A, Guehairia S et al. · Neuropharmacology · 2024
04delivery · release22편
- 0.67
Chen C, Leung C, Zhai Z et al. · Pharmaceutics · 2026
- 0.66
Modulation of experimental Alzheimer's disease in rats through donepezil-loaded CSF implant
Osama L, ElShebiney S, Beherei HH et al. · Scientific reports · 2025
- 0.64
Khairnar P, Singh A, Ahirwar K et al. · AAPS PharmSciTech · 2023
- 0.63
Wang G, Duan X, Ouyang D et al. · Asian journal of pharmaceutical sciences · 2026
- 0.62
Braeckman R, Oh C · Neurodegenerative disease management · 2023
- 0.58
Ilyas NRA, Putri APD, Pratama FA et al. · European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2024
- 0.57
Valis M, Dlabkova A, Hort J et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
- 0.57
Kaur A, Nigam K, Tyagi A et al. · AAPS PharmSciTech · 2022
- 0.56
Park YC, Seol E, Lee J et al. · Pharmaceutics · 2025
- 0.56
Ji YB, Lee S, Ju HJ et al. · Journal of controlled release : official journal of the Controlled Release Society · 2023
- 0.55
Morgan TM, Snyder B · Journal of clinical pharmacology · 2026
- 0.55
Shehata MK, Ismail AA, Kamel MA · International journal of nanomedicine · 2023
- 0.54
Guo H, Wang G, Zhai Z et al. · International journal of pharmaceutics · 2024
- 0.54
Roy H, Maddiboyina B, Nandi S et al. · Nanomedicine : nanotechnology, biology, and medicine · 2025
- 0.53
Kaboli Z, Hosseini MJ, Sadighian S et al. · International journal of pharmaceutics · 2023
- 0.53
Monou PK, Saropoulou E, Junqueira LA et al. · European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2025
- 0.52
Qian L, Cui M, Wu M et al. · Journal of nanobiotechnology · 2026
- 0.52
Wei DX, Cai D, Tan Y et al. · International journal of biological macromolecules · 2024
- 0.52
Brain targeting efficacy of novel drug delivery system in the treatment of Alzheimer's disease
Duan LH, Li LM, Wang CB et al. · European review for medical and pharmacological sciences · 2024
- 0.51
Wen S, Gao J, Wang Z et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
- 0.51
Vasileva L, Gaynanova G, Valeeva F et al. · International journal of molecular sciences · 2023
- 0.50
Avendano-Godoy J, Miranda A, Mennickent S et al. · Journal of pharmaceutical sciences · 2023
05review · strategies3편
- 0.75
Fide E, Polat H, Yener G et al. · Brain topography · 2023
- 0.61
Nagy LV, Bali ZK, Ledneczki I et al. · ASN neuro · 2024
- 0.61
Tiunova AA, Diffine EA, Anokhin KV · Frontiers in cellular neuroscience · 2025
06molecular dynamics · docking1편
- 0.54
Hanumanthappa D, Kumar BS, Shajan SRO et al. · Scientific reports · 2025
07synthesized · derivatives1편
- 0.52
Zueva IV, Vasilieva EA, Gaynanova GA et al. · International journal of molecular sciences · 2023